Prof. Yantao Tian 田艳涛
Chief Physician, Professor
Department of Pancreatic and Gastric Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric cancer, gastroesophageal junction tumors, gastrointestinal stromal tumors, pancreatic cancer, splenic tumors, duodenal tumors, ampullary bile duct cancer, and jejunal, ileal, and appendiceal tumors.
Dr. Tian is Chief of the Pancreatic and Gastric Surgery Ward at Cancer Hospital, Chinese Academy of Medical Sciences. A visiting scholar at MD Anderson Cancer Center (2011–2012), Dr. Tian performs laparoscopic gastric and pancreatic surgeries. Dr. Tian authored science popularization books on gastric cancer prevention.
Professional roles
- Standing Committee Member and Chair of the Science Popularization Branch, China International Exchange and Promotion Association for Medical and Health Care
- Vice Chairman, Beijing Green Medical New Technology Industry Alliance
- Deputy Standing Committee Member, Upper Gastrointestinal Surgery Group, Surgical Physician Branch, Chinese Medical Doctor Association
- Standing Committee Member, Tumor Prevention and Standardized Training Working Committee, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Tian Yantao). Papers usually list the name as Yantao Tian or Tian Y.
Selected publications
134 papers on PubMed matched by name and affiliation; 70 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Gastrointest Oncol, 2026 (senior author): Neoadjuvant therapy-related skeletal muscle reduction and postoperative outcomes after gastrectomy for gastric cancer: a systematic review and meta-analysis. PubMed 42996835
- Sci China Life Sci, 2026 (senior author): Neoadjuvant therapy reshapes the therapeutic value of distal lymphadenectomy in cT3/4a proximal gastric cancer. PubMed 42773378
- Int J Cancer, 2026 (senior author): Neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S-1 versus oxaliplatin and S-1 for locally advanced gastric adenocarcinoma: A multicenter, real-world cohort study. PubMed 41450028
- Front Nutr, 2026 (senior author): Development and validation of a novel prognostic model for gastric signet ring cell carcinoma based on inflammation-nutrition indicators. PubMed 42005437
- Cancer Lett, 2026 (senior author): Exosomal circUBR5 drives metastasis and chemoresistance in gastric signet-ring cell carcinoma by reprogramming cholesterol metabolism through the hsa-miR-1208/CYP19A1 axis and ACAT1 upregulation. PubMed 41580013
- World J Surg Oncol, 2025 (senior author): The relationship between examined lymph nodes and oncological outcome of proximal gastrectomy for Siewert II/III adenocarcinoma of the esophagogastric junction. PubMed 41310607
- J Gastrointest Oncol, 2025 (senior author): Application of modified laparoscopic stomach-partitioning gastrojejunostomy for stage IV gastric cancer with gastric outlet obstruction. PubMed 41220731
- J Gastric Cancer, 2025 (senior author): Is Proximal Gastrectomy Oncologically Justifiable for Advanced Siewert II/III Adenocarcinoma of the Esophagogastric Junction?. PubMed 41093774
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion